title: A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
authors.affiliation: Memorial Cancer Center, Department of Urology, Warwaw, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Pawinski
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: C
authors.initials: C
authors.lastname: Bouffioux
authors.forename: K H
authors.initials: KH
authors.lastname: Kurth
authors.forename: M
authors.initials: M
authors.lastname: Parmar
authors.forename: L
authors.initials: L
authors.lastname: Bijnens
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control* / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents